BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 15337790)

  • 1. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
    Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
    Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
    Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
    Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    J Cell Sci; 2002 Jun; 115(Pt 11):2329-37. PubMed ID: 12006617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
    Rojnuckarin P; Drachman JG; Kaushansky K
    Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
    EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin signal transduction: studies from cell lines and primary cells.
    Drachman JG; Rojnuckarin P; Kaushansky K
    Methods; 1999 Mar; 17(3):238-49. PubMed ID: 10080909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cells.
    Dorsch M; Danial NN; Rothman PB; Goff SP
    Blood; 1999 Oct; 94(8):2676-85. PubMed ID: 10515871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
    Broudy VC; Lin NL
    Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
    Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
    Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
    Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
    Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
    Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
    Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
    Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
    Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.